CPL-200-075

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameCPL-200-075
Drug Alias NameSGLT-2 inhibitor (Celon Pharma)sodium-glucose cotransporter 2 inhibitor (Celon Pharma)CPL-200-075
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium/glucose cotransporter 2 inhibitors
TargetsSodium/glucose cotransporter 2
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryPoland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelon Pharma SP
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelon Pharma SP
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A